| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/20/2011 | WO2011007138A1 Method and apparatus for determining an analyte parameter |
| 01/20/2011 | WO2011007130A1 Therapeutic peptides, polypeptides ans nucleic acid sequences |
| 01/20/2011 | WO2011007049A1 Use of animal cells for screening probiotic bacteria strains |
| 01/20/2011 | WO2011007007A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 01/20/2011 | WO2011006988A1 Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors |
| 01/20/2011 | WO2011006962A1 Nucleic acid expression construct and its use as a cell proliferation marker |
| 01/20/2011 | WO2011006911A2 Mass spectrometric diagnosis of septicemia |
| 01/20/2011 | WO2011006909A2 Marker sequences for adiposity |
| 01/20/2011 | WO2011006891A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| 01/20/2011 | WO2011006871A1 INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE |
| 01/20/2011 | WO2011006645A1 Apparatus for monitoring mechanical properties of a moving filamentary or planar body and monitoring process |
| 01/20/2011 | WO2011006642A1 Flap endonuclease-1 as a marker for cancer |
| 01/20/2011 | WO2011006249A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | WO2011006214A1 Method of detecting radiation exposure and adverse toxicity thereto |
| 01/20/2011 | WO2010136629A9 Methods for the diagnosis or prognosis of colorectal cancer |
| 01/20/2011 | WO2010135541A3 Variants of c-type natriuretic peptide |
| 01/20/2011 | WO2010120818A3 Ensemble-decision aliquot ranking |
| 01/20/2011 | WO2010120769A3 Method and apparatus for multimodal imaging of biological tissue |
| 01/20/2011 | WO2010119261A8 Method for quantifying modified peptides |
| 01/20/2011 | WO2010118706A4 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
| 01/20/2011 | WO2010118404A3 Methods for creating or identifying compounds that bind tumor necrosis factor alpha |
| 01/20/2011 | WO2010118243A3 Use of il-27 antagonists to treat lupus |
| 01/20/2011 | WO2010115123A3 Variable volume mixing and automatic fluid management for programmable microfluidics |
| 01/20/2011 | WO2010115061A9 Biomarkers for monitoring treatment of neuropsychiatric diseases |
| 01/20/2011 | WO2010114297A3 Microsphere having hot spots and method for identifying chemicals through surface enhanced raman scattering using the same |
| 01/20/2011 | WO2010111531A3 Device for detecting an analyte |
| 01/20/2011 | WO2010111403A3 Probablistic pharmacokinetic and pharmacodynamic modeling |
| 01/20/2011 | WO2010110623A9 System and method for providing an oil and moisture index for cosmetics |
| 01/20/2011 | WO2010099154A3 Analyte sensor offset normalization |
| 01/20/2011 | WO2010093861A4 System, method and device for tissue-based diagnosis |
| 01/20/2011 | WO2010093209A3 Use of caveolin-1 as biomarker diagnosing wound healing ability after ophthalmological surgery and method for diagnosing wound healing ability using the same |
| 01/20/2011 | WO2010092185A3 Scramblase/cd4 interaction inhibitors for the treatment of lentivirus infections |
| 01/20/2011 | WO2010091021A3 Oligomer sequences mapping |
| 01/20/2011 | WO2010082133A8 Screening method for the identification of tnf-pathway modulators using tradd /reporter fusion protein |
| 01/20/2011 | WO2010080962A3 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 01/20/2011 | WO2010077323A3 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders |
| 01/20/2011 | WO2009010678A3 Method of determining the fuel content in a combustion engine lubricating oil |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110016591 Resistance to auxinic herbicides |
| 01/20/2011 | US20110016590 Resistance to auxinic herbicides |
| 01/20/2011 | US20110016543 Genomic editing of genes involved in inflammation |
| 01/20/2011 | US20110016542 Canine genome editing with zinc finger nucleases |
| 01/20/2011 | US20110016541 Genome editing of sensory-related genes in animals |
| 01/20/2011 | US20110016540 Genome editing of genes associated with trinucleotide repeat expansion disorders in animals |
| 01/20/2011 | US20110016539 Genome editing of neurotransmission-related genes in animals |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015872 Chemical sensors based on cubic nanoparticles capped with an organic coating for detecting explosives |
| 01/20/2011 | US20110015867 Method for redesign of microbial production systems |
| 01/20/2011 | US20110015866 Active Interface Device |
| 01/20/2011 | US20110015865 Determination of coronary artery disease risk |
| 01/20/2011 | US20110015863 Method for identification and sequencing of proteins |
| 01/20/2011 | US20110015511 Systems and methods for optimizing insulin dosage |
| 01/20/2011 | US20110015381 Instrument and method for collecting nucleic acids |
| 01/20/2011 | US20110015375 Methods for Identifying and Using MarR Family Polypeptide Binding Compounds |
| 01/20/2011 | US20110015259 Tle3 as a marker for chemotherapy |
| 01/20/2011 | US20110015254 PTPH1 Inhibitors for the Treatment of Alzheimer's Disease |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| 01/20/2011 | US20110015139 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/20/2011 | US20110015136 humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 01/20/2011 | US20110015133 Pax2 and pax8 as tumour targets for immunologic and molecular treatment strategies |
| 01/20/2011 | US20110015097 Support carrying an immobilized selective binding substance |
| 01/20/2011 | US20110015090 Markers of Acute Myeloid Leukemia Stem Cells |
| 01/20/2011 | US20110015088 Biocatalytic solgel microarrays |
| 01/20/2011 | US20110015087 Detection of endometrial secretion markers for assessment of endometriosis |
| 01/20/2011 | US20110015084 Methods for Identifying Genetic Linkage |
| 01/20/2011 | US20110014724 Method of detecting bioproducts using localized surface plasmon resonance sensor of gold nanoparticles |
| 01/20/2011 | US20110014723 Compositions and processes relating to human bocavirus |
| 01/20/2011 | US20110014721 Hydrophilic chemiluminescent acridinium labeling reagents |
| 01/20/2011 | US20110014718 Device and method for pressure and flow control in parallel reactors |
| 01/20/2011 | US20110014717 Sensor System and Methods for Chemical Detection |
| 01/20/2011 | US20110014716 Compositions and methods for diagnosing and treating macular degeneration |
| 01/20/2011 | US20110014715 Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application |
| 01/20/2011 | US20110014714 Method for selective labeling of protein produced by in vitro translation by using a marker from trna prepared by using in vitro transcription |
| 01/20/2011 | US20110014713 Detection method and determination method for detection target |
| 01/20/2011 | US20110014712 Method, device and apparatus for measuring the concentration of creatinine, and method, device and apparatus for measuring the amount of salt using the same |
| 01/20/2011 | US20110014710 Compositions, methods and kits for biarsenical fluorophore labeling |
| 01/20/2011 | US20110014641 Method for measuring aromatase activity |
| 01/20/2011 | US20110014639 Hybridoma cell line producing monoclonal antibody against foot-and-mouth disease virus, the monoclonal antibody therefrom, immunoassay reagent and kit, and immunoassay method |
| 01/20/2011 | US20110014638 Soluble fas in acute coronary syndromes diagnosis |
| 01/20/2011 | US20110014637 Method For Determining The Sensitivity Of Patients Suffering From A Cancer Disease To Biological Therapy |
| 01/20/2011 | US20110014636 Method of detecting leukemic cell |
| 01/20/2011 | US20110014635 Marker peptide for alzheimer's disease |
| 01/20/2011 | US20110014634 Nucleic acids encoding t2r, a novel family of taste receptors |
| 01/20/2011 | US20110014633 Electric analysis method |
| 01/20/2011 | US20110014632 Assays for clinical assessments of rheumatoid arthritis |
| 01/20/2011 | US20110014631 Method for diagnosing acute coronary syndrome |
| 01/20/2011 | US20110014630 Fluorescent Carbon Nanoparticles |
| 01/20/2011 | US20110014629 Methods for improving the recovery of troponin i and t in membranes, filters and vessels |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014627 Method for determining antagonist activity to a cytokinin receptor |
| 01/20/2011 | US20110014626 Methods for measuring the insulin receptor alpha subunit |
| 01/20/2011 | US20110014610 Compositions and methods for diagnosing and treating neuropsychiatric disorders |
| 01/20/2011 | US20110014608 SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES |
| 01/20/2011 | US20110014604 Methods for sequence determination |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014328 Functionally superior whey proteins |
| 01/20/2011 | US20110014225 Cross-reactive determinants and methods for their identification |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |